Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases.

Cancer Commun (Lond) · 2018 · PMC6020209 · PMID 29941039

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

likely to be significantno p-value reported

Savings to national health systems associated with the use of metronomic capecitabine are therefore likely to be significant compared with sorafenib treatment.

also in 1,824 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.